Hyaluronic Acid Raw Material Market Report by Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Device Coating, Surgical Adhesion Prevention, Biomaterials and Implants, Cell and Tissue Preservation), and Region 2024-2032

Hyaluronic Acid Raw Material Market Report by Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Device Coating, Surgical Adhesion Prevention, Biomaterials and Implants, Cell and Tissue Preservation), and Region 2024-2032


The global hyaluronic acid raw material market size reached US$ 7.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements.

Hyaluronic Acid Raw Material Market Trends:

Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hyaluronic acid raw material market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application.

Breakup by Application:
  • Ophthalmology
  • Cataract Surgery
  • Aqueous Eye Drop
  • Contact Lens
  • Orthopedics
  • Viscosupplements
  • Bone Regeneration
  • Dermatology
  • Intradermal
  • Dermal Filler
  • Wound Healing
  • Drug Delivery
  • Medical Device Coating
  • Surgical Adhesion Prevention
  • Biomaterials and Implants
  • Cell and Tissue Preservation
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet.

Key Questions Answered in This Report:
  • How has the global hyaluronic acid raw material market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hyaluronic acid raw material market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hyaluronic acid raw material market and who are the key players?
  • What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hyaluronic Acid Raw Material Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Ophthalmology
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Cataract Surgery
6.1.2.2 Aqueous Eye Drop
6.1.2.3 Contact Lens
6.1.3 Market Forecast
6.2 Orthopedics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Viscosupplements
6.2.2.2 Bone Regeneration
6.2.3 Market Forecast
6.3 Dermatology
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Intradermal
6.3.2.2 Dermal Filler
6.3.2.3 Wound Healing
6.3.3 Market Forecast
6.4 Drug Delivery
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Medical Device Coating
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Surgical Adhesion Prevention
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Biomaterials and Implants
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Cell and Tissue Preservation
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Region
7.1 North America
7.1.1 United States
7.1.1.1 Market Trends
7.1.1.2 Market Forecast
7.1.2 Canada
7.1.2.1 Market Trends
7.1.2.2 Market Forecast
7.2 Asia-Pacific
7.2.1 China
7.2.1.1 Market Trends
7.2.1.2 Market Forecast
7.2.2 Japan
7.2.2.1 Market Trends
7.2.2.2 Market Forecast
7.2.3 India
7.2.3.1 Market Trends
7.2.3.2 Market Forecast
7.2.4 South Korea
7.2.4.1 Market Trends
7.2.4.2 Market Forecast
7.2.5 Australia
7.2.5.1 Market Trends
7.2.5.2 Market Forecast
7.2.6 Indonesia
7.2.6.1 Market Trends
7.2.6.2 Market Forecast
7.2.7 Others
7.2.7.1 Market Trends
7.2.7.2 Market Forecast
7.3 Europe
7.3.1 Germany
7.3.1.1 Market Trends
7.3.1.2 Market Forecast
7.3.2 France
7.3.2.1 Market Trends
7.3.2.2 Market Forecast
7.3.3 United Kingdom
7.3.3.1 Market Trends
7.3.3.2 Market Forecast
7.3.4 Italy
7.3.4.1 Market Trends
7.3.4.2 Market Forecast
7.3.5 Spain
7.3.5.1 Market Trends
7.3.5.2 Market Forecast
7.3.6 Russia
7.3.6.1 Market Trends
7.3.6.2 Market Forecast
7.3.7 Others
7.3.7.1 Market Trends
7.3.7.2 Market Forecast
7.4 Latin America
7.4.1 Brazil
7.4.1.1 Market Trends
7.4.1.2 Market Forecast
7.4.2 Mexico
7.4.2.1 Market Trends
7.4.2.2 Market Forecast
7.4.3 Others
7.4.3.1 Market Trends
7.4.3.2 Market Forecast
7.5 Middle East and Africa
7.5.1 Market Trends
7.5.2 Market Breakup by Country
7.5.3 Market Forecast
8 SWOT Analysis
8.1 Overview
8.2 Strengths
8.3 Weaknesses
8.4 Opportunities
8.5 Threats
9 Value Chain Analysis
10 Porters Five Forces Analysis
10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes
11 Price Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
12.3.1 AbbVie Inc.
12.3.1.1 Company Overview
12.3.1.2 Product Portfolio
12.3.1.3 Financials
12.3.1.4 SWOT Analysis
12.3.2 Anika Therapeutics Inc.
12.3.2.1 Company Overview
12.3.2.2 Product Portfolio
12.3.2.3 Financials
12.3.2.4 SWOT Analysis
12.3.3 Contipro a.s.
12.3.3.1 Company Overview
12.3.3.2 Product Portfolio
12.3.4 Galderma S.A.
12.3.4.1 Company Overview
12.3.4.2 Product Portfolio
12.3.5 LG Chem Ltd.
12.3.5.1 Company Overview
12.3.5.2 Product Portfolio
12.3.5.3 Financials
12.3.5.4 SWOT Analysis
12.3.6 Lifecore Biomedical LLC (Landec Corporation)
12.3.6.1 Company Overview
12.3.6.2 Product Portfolio
12.3.7 Sanofi S.A.
12.3.7.1 Company Overview
12.3.7.2 Product Portfolio
12.3.7.3 Financials
12.3.7.4 SWOT Analysis
12.3.8 Seikagaku Corporation
12.3.8.1 Company Overview
12.3.8.2 Product Portfolio
12.3.8.3 Financials
12.3.9 Smith & Nephew plc
12.3.9.1 Company Overview
12.3.9.2 Product Portfolio
12.3.9.3 Financials
12.3.9.4 SWOT Analysis
12.3.10 Zimmer Biomet
12.3.10.1 Company Overview
12.3.10.2 Product Portfolio
12.3.10.3 Financials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings